Quantitative Investment Management’s Emergent Biosolutions EBS Stock Holding History

Quantitative Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,035	Closed	-$201K	–	371
2024 Q4	$201K	Buy	+21,035	New	+$193K	0.02%	310
2020 Q4	–	Sell	-10,941	Closed	-$1.13M	–	491
2020 Q3	$1.13M	Buy	+10,941	New	+$1.18M	0.1%	174
2019 Q4	–	Sell	-29,862	Closed	-$1.56M	–	664
2019 Q3	$1.56M	Buy	+29,862	New	+$1.39M	0.08%	277
2018 Q4	–	Sell	-5,200	Closed	-$342K	–	633
2018 Q3	$342K	Buy	+5,200	New	+$303K	0.01%	494
2018 Q1	–	Sell	-18,000	Closed	-$836K	–	784
2017 Q4	$836K	Sell	18,000 -36,100	-67%	-$1.52M	0.01%	622
2017 Q3	$2.19M	Buy	+54,100	New	+$1.96M	0.03%	480
2017 Q1	–	Sell	-54,200	Closed	-$1.78M	–	741
2016 Q4	$1.78M	Buy	+54,200	New	+$1.62M	0.04%	512

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantitative Investment Management's EBS Position: Q1 2025 in Review

Quantitative Investment Management sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 21,035 shares — an estimated $201K sold.

Quantitative Investment Management first reported a position in EBS in Q4 2016 and held it in 7 quarters. The position peaked at $2.19M in Q3 2017. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.

Quantitative Investment Management reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
Quantitative Investment Management sold 21,035 Emergent Biosolutions shares in Q1 2025, an estimated $201K.
Quantitative Investment Management first reported a position in Emergent Biosolutions in Q4 2016 and held it in 7 quarters.
Quantitative Investment Management's Emergent Biosolutions position peaked at $2.19M in Q3 2017.
160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.

Based on Quantitative Investment Management's 13F filing for Q1 2025, filed 14 May 2025.